Articles On Alcidion Group (ASX:ALC)

The past fortnight saw ~$62.79m in big director sales and a more modest ~$20.5m in buys but the biggest buy of the week came from a relatively new gold producer. Emerald Resources (ASX:EMR) director Ross Stanley bought just over $1 million...

You can’t win them all, especially in the stock market investing game. Each month you’ll see some of your ASX shares plunge in value. During market downturns you might even see your entire portfolio in the red. But short term movements, ex...

Welcome to the Market Herald Deal Room for this Friday, where we review the week in capital raising. Cobram Estate Olives (ASX:CBO), which only joined the ASX in August and now has a $1 million SPP opening on Monday after raising $50 mil...

Live on The Australian Investors Podcast this week, your weekly hosts Owen Rask & 7Investing’s Dr Anirban Mahanti talk Magellan Financial Group Ltd (ASX: MFG), US cybersecurity stocks, ASX small-cap Alcidion Group Ltd (ASX: ALC) and mor...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week It’s been a...

There were few major catalysts on Thursday, as the ASX traded flat in a relatively cruisy session following some solid gains this week. Broadly speaking, the ASX has tracked global stock markets higher after a rocky selloff last week that f...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to continue its winning streak but is falling just a touch short. At the time of writing, the benchmark index is down slightly to 7,401.7 points. Four ASX shares tha...

The Alcidion Group Ltd (ASX: ALC) share price is deep in the red today after exiting its trading halt this morning. Shares in the company opened around 14% lower and have remained at that level, trading at 27.5 cents apiece at the time of...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Alcidion (ALC) successfully completes its placement and institutional entitlement offer and raises $43.4 million Yesterday, the company announced it was looking to raise $55 million to buy patient software specialists, Silverlink PCS Softw...

The ASX had another day of solid gains, hitting a three week high with tech and resources leading the charge. The ASX 200 rose 1.25%, closing at 7,405 and while all sectors were in the green, resources and tech both were the best – gaining...

The ASX finished 0.67% higher, marking the best performance by the Australian bourse since early October. Almost all sectors finished higher with energy and tech – two sectors under siege in recent weeks – recording gains of 2.07% and 1.9%...

The Alcidion Group Ltd (ASX: ALC) share price is frozen today with the company announcing it will acquire Silverlink PCS Software Limited. The healthcare technology company’s shares were at 32 cents before the trading halt was announced j...

Alcidion (ALC) has announced plans to raise $55 million and buy patient software specialists, Silverlink PCS Software The ASX-lister will pay £30 million (A$55.5 million) for the Patient Administration System (PAS) providers, which service...

03 Dec 2021 - Alcidion Group Limited (ASX:ALC), as part of a consortium of digital health partners led by Leidos, has been awarded a contract for an estimated $23.5 million over si…

The ASX 200 Health Index (XHJ) is down by 0.67% at the time of writing, compared to the broader index which is up by 0.47%. Alcidion Group (ASX:ALC) rose nearly 8% this morning, after revealing that it was a member of a consortium awarded a...

The Alcidion Group Ltd (ASX: ALC) share price is on course to end the week on a very positive note. In morning trade, the healthcare technology company’s shares are up 11% to 35 cents. Why is the Alcidion share price rocketing higher? Inve...

Alcidion (ALC) has signed a contract with Leidos Australia to provide its platform to a healthcare IT project for the Commonwealth of Australia Alcidion was selected as part of a consortium for the six-year contract which will see it provi...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future. Two that investors may want to get better acquainted with are listed below. Here’s what you need to know...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been tipped for big things in the future. Here’s why these small cap ASX shar...

Highlights The Australian government announced a budget for FY2021-2022 to support AI technology in Australia. AI has the potential to overcome the challenges businesses and governments face in their operations. ASX-listed players ALC...

The Alcidion Group Ltd (ASX: ALC) share price is in negative territory today following the company’s latest quarterly update. During early afternoon trade, the healthcare technology company’s shares are down 4.17% to 34.5 cents. How did Al...

At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future. Three that investors may want to get better acquainted with are listed below. Here’s what you need to kno...

Alcidion Group (ALC) expands the use of its remote patient monitoring platform, Miya Precision, with the Sydney Local Health District (LHD) The contract extension will generate around an additional $1.8 million in revenue over the next thr...

It’s been a busy morning for the ASX Healthcare sector, with plenty of positive announcements for investors to digest. But the Health Index (XHJ) is trading down by 0.5% at the time of writing, compared to the broader index which is trading...

The Alcidion Group Ltd (ASX: ALC) share price is rocketing higher today after the company announced the Sydney Local Health District has expanded its use of Miya Precision. The expanded agreement will see Alcidion with an extra $1.8 millio...

Wall Street advances on strong earnings US stocks advanced on Friday on strong corporate earnings which were highlighted by record investment banking fees. Goldman Sachs’s beat analysts’ expectations and pulled in US$3.7bn in M&A adviso...

Alcidion Group (ALC) further expands the use of ExtraMed’s IPFM to Queen’s Hospital Burton in England IPFM is ExtraMed’s patient flow management software that allows frontline staff to make informed decisions based on real-time visibility...

Looking to celebrate this month with some investment treats? We asked our Foolish contributors to compile a list of some of the ASX shares experts are saying to buy in October. Tristan Harrison: Volpara Health Technologies Ltd (ASX: VHT) ...

At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future. Two that investors may want to get better acquainted with are listed below. Here’s what you need to know...

At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future. Three that investors may want to get better acquainted with are listed below. Here’s what you need to kno...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

The small end of the Australian share market is home to a number of companies with the potential to grow strongly in the future. Three small caps that investors may want to get better acquainted with are listed below. Here’s why they shoul...

Highlights Low interest rate scenario is conducive for growth stocks. The technology sector has witnessed a major tail wind since the rapid digitisation post the COVID-19 outbreak. Knosys is to acquire a leading Library Management Sof...

The Alcidion Group [ASX:ALC] reported record revenue for FY21 of $25.9 million. The record revenue was not enough to increase ALC’s shares, with the Alcidion stock currently down 1.5%. The post Alcidion Posts Record FY21 Revenue but Shares...

“We have a tremendous growth opportunity ahead of us in the new financial year as Alcidion builds on the record-breaking momentum created in FY21,” says MD.

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been tipped for big things in the future. Here’s why these small cap ASX shar...

Buy ASX shares for the long term, we’re always told. Don’t try to time the market. But the irony is the same experts that espouse this to retail investors don’t, or can’t, follow it themselves. That’s because fund managers are judged by po...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

Are you interested in small cap shares? If you are, then you may want to look at the ones listed below. Both these small cap ASX shares have been given buy ratings and are tipped for big things in the future. Here’s what you need to know:...

The ASX 200 touched intraday record highs, but could not hold on and closed the day just shy of its all time high. The benchmark index finished 0.46% higher at 7,428, and is now on track to finish July on a 10-month winning streak. Six out...

The Alcidion Group Ltd (ASX: ALC) share price is delivering gains to shareholders on Tuesday. At the time of writing, the healthcare software provider’s shares are swapping hands for 40.5 cents, up 14%. Why is the Alcidion share price surg...

Leading the ASX companies rising thanks to financial updates were a number of beneficiaries of the COVID-19 tech boom. As the week when quarterlies are due progresses and the market announcements page becomes increasingly flooded with lodge...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Ask A Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, Cyan Investment Management portfolio manager Dean Fergie tips 2 ASX shares flying under the radar...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...